| Tag | Content |
|---|
EnhancerAtlas ID | HS060-31621 |
Organism | Homo sapiens |
Tissue/cell | GM12891 |
Coordinate | chr7:50480290-50481070 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ESRRB | MA0141.3 | chr7:50480898-50480909 | TCAAGGTCATA | + | 6.62 | | Esrra | MA0592.2 | chr7:50480897-50480908 | TTCAAGGTCAT | + | 6.62 | | Esrrg | MA0643.1 | chr7:50480898-50480908 | TCAAGGTCAT | + | 6.02 | | Nr5a2 | MA0505.1 | chr7:50480779-50480794 | CCTGACCTTGAAGCT | - | 6.05 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_09412 | chr7:50468289-50485837 | CD14 | | SE_10357 | chr7:50471995-50482114 | CD19_Primary | | SE_10918 | chr7:50410368-50486056 | CD20 | | SE_61918 | chr7:50458805-50486267 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH07I050412 | chr7 | 50480430 | 50481658 |
|
Enhancer Sequence | CAGCAAGCAA AGGCATCAGG GTAAATGGGG GCATTCTATA ATGACACGGG GGTCAATTTT 60
CCAACAAGAT GTAACAATCC TTAGCATGTG CATGCCTAAC AACAGAGCAC CAGCATACAT 120
GAGGCAAAAG CGGAGAGAAC CACACAGAAA TCAATGAACC CACTCCTAGA GCTGGAGACT 180
CCAACATTCC CCATCAGAAA TGGACAGATC CAGCAGGCAG AAAATCAGTA AGGATGTAGT 240
TGAACTGAAA GACAGGAGTT ATTTGGGCAA AGAAAGGCAG CAGACAGTTT CAGGCAGAGG 300
GGGCAGCGTG AATGCGGTAC AGAGGCCTGG ACACGGAATA GTGCTGAAGG AAGGCAAGGC 360
CGTGTGGCTG GGCTGGAGGA GTGTCCTGGG GGCTGGGGAG TGCCAGACGC CTGGAGAGAA 420
GGGGTCCACC ATTCAGCCAA AGAGGTGCCC TCTGAGGGTT GGGGAAGGCA GCAGGAGCTG 480
AGCCCCTGTC CTGACCTTGA AGCTGCAGGG CTGTCATGAA TGCATGGGCC CCCTGAGGAA 540
GGGCGGAGAG GGGTGTGAGC ACCAATTTCA GGTAGTGAAA CTAAGGCCAA GGAAGCAGAG 600
AGCCGTTTTC AAGGTCATAG GGAGTCACCC TCAAGCCACA TTTCCTAAAG CCCATTATGC 660
ATAATGCAAA AAAGGAGAAT GGGGCAAACG ATTTGGGAAA AGCCACACAC TCTTCCCTCT 720
TTTGGAGATC CACAATGTGC CTTAGCATTT GAAATGCCCT GGGCAGAATA GAAGATGGTT 780
|
